Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3
The experimentally established mechanism targets of Alloclamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.37 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.37 |
| ▸ | MCHR1 | Q99705 | 10/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.39 |
| ▸ | SCN1A | P35498 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.39 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
| ▸ | GHSR | Q92847 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alloclamide SCHEMBL209095 | 0.86 | MCHR1 (0.52) | MCHR1ALDH1A1KDM4ESMN1; SMN2GAA | |
| Alloclamide SCHEMBL29730070 | 0.85 | MCHR1 (0.53) | MCHR1ALDH1A1KDM4ESMN1; SMN2GAA | |
| Alloclamide SCHEMBL872157 | 0.85 | MCHR1 (0.53) | MCHR1ALDH1A1KDM4ESMN1; SMN2GAA | |
| Alloclamide SCHEMBL27527103 | 0.83 | MCHR1 (0.51) | MCHR1ALDH1A1KDM4ESMN1; SMN2GAA | |
| SCHEMBL30391813 | 0.76 | HPGD (0.50) | MCHR1ALDH1A1HTTSMN1; SMN2GAA | |
| SCHEMBL6365174 | 0.75 | LIG1 (0.60) | MCHR1ALDH1A1KDM4ESMN1; SMN2HPGD | |
| Flualamide SCHEMBL29804765 | 0.71 | MCHR1 (0.58) | MCHR1ALDH1A1LMNARAB9ATSHR | |
| Flualamide SCHEMBL2734613 | 0.71 | MCHR1 (0.58) | MCHR1ALDH1A1LMNARAB9ATSHR | |
| SCHEMBL30358593 | 0.70 | GAA (0.53) | GAAHPGDLMNACYP1A2RAB9A | |
| SCHEMBL10656342 | 0.68 | ADRA2A (0.49) | MCHR1ALDH1A1KDM4ESMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0330180-B2 | Polylactic acid type microspheres containing physiologically active substance and process for preparing the same | BIOMATERIALS UNIVERSE INC (JP) | 1999-03-03 | — | — | EP | disclosed |